홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

메타비탈CIII(200MG)

Metharbital

HCID 4099
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
50-11-3
표준 SMILES
CCC1(CC)C(=O)NC(=O)N(C)C1=O
InChIKey
FWJKNZONDWOGMI-UHFFFAOYSA-N
분자식
C9H14N2O3
평균 분자량
198.22 g/mol
단동위원소 질량
198.10044231

개요

Metharbital is an organic molecular entity.

이름 및 식별자

우선 이름
Metharbital
IUPAC
5,5-diethyl-1-methyl-1,3-diazinane-2,4,6-trione
현지명
메타비탈CIII(200MG)
영어명
METHARBITAL CIII (200 MG)
분자식
C9H14N2O3
분자량
198.22

이름 및 동의어

metharbitalMetharbitoneGemonil50-11-3MetarbitalEndiemal5,5-Diethyl-1-methylbarbituric acid5,5-diethyl-1-methyl-1,3-diazinane-2,4,6-trioneMetharbitalumMetharbital ciiiDTXSID60232802,4,6(1H,3H,5H)-Pyrimidinetrione, 5,5-diethyl-1-methyl-
이름 더 보기
메타비탈CIII(200MG)Methylbarbitalan23AN 23sch412GemonalGemonitSch 412Endiemalum
NSC-2715602OS7K758TDTXCID1032805,5-diethyl-6-hydroxy-3-methyl-2,3,4,5-tetrahydropyrimidine-2,4-dionemethobarbitoneRefChem:57479N03AA30200-011-2

데이터베이스 식별자

CAS
50-11-3
PubChem CID
4099
DTXSID
DTXSID6023280
ChEMBL
CHEMBL450
ChEBI
CHEBI:31827
UNII
02OS7K758T
EC Number
200-011-2
Nikkaji
J1.357I

물성

구조 계산 물성

XLogP
1.2
극성 표면적
66.5 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
3
회전 가능 결합 수
2
무거운 원자 수
14
형식 전하
0
복잡도
294

실험 및 물리화학적 성질

Drugs · 3건

DEA NFLIS-Drug Category -> Depressants and Tranquilizers

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Barbiturates

SpringerMaterials PropertiesNuclear quadrupole resonance spectroscopy
LogP · 2건

0.6

1.15

Solubility1.95e+01 g/L
Human Drugs · 2건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Melting Point150.5 °C
Physical DescriptionSolid
Dissociation Constants8.01 (at 25 °C)

물리화학적 성질

녹는점
155 ° · 155°
끓는 점
335.53 °C · 335.53°C (rough estimate)
밀도
1.2119 · 1.2119 (rough estimate)

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H400 (100%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]

P273, P391, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

독성 정보

Health EffectsMay cause a potentially dangerous rash that may develop into Stevens Johnson syndrome, an extremely rare but potentially fatal skin disease.
Toxicity Summary · 1건

Metharbital binds at a distinct binding site associated with a Cl<sup>-</sup> ionopore at the GABA<sub>A</sub> receptor, increasing the duration of time for which the Cl<sup>-</sup> ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged. All of these effects are associated with marked decreases in GABA-sensitive neuronal calcium conductance (gCa). The net result of barbiturate action is acute potentiation of inhibitory GABAergic tone. Barbiturates also act through potent (if less well characterized) and direct inhibition of excitatory AMPA-type glutamate receptors, resulting in a profound suppression of glutamatergic neurotransmission.

Signs and Symptoms · 1건

Signs of overdose include confusion (severe), decrease in or loss of reflexes, drowsiness (severe), fever, irritability (continuing), low body temperature, poor judgment, shortness of breath or slow or troubled breathing, slow heartbeat, slurred speech, staggering, trouble in sleeping, unusual movements of the eyes, weakness (severe).

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

안전 데이터

화학 및 산업

약리 정보

ATC Code · 2건

N - Nervous system

QN - Nervous system

Pharmacodynamics · 1건

Metharbital, a barbiturate, is used for the treatment of short term insomnia. It belongs to a group of medicines called central nervous system (CNS) depressants that induce drowsiness and relieve tension or nervousness. Little analgesia is conferred by barbiturates; their use in the presence of pain may result in excitation.

Mechanism of Action · 1건

Metharbital binds at a distinct binding site associated with a Cl<sup>-</sup> ionopore at the GABA<sub>A</sub> receptor, increasing the duration of time for which the Cl<sup>-</sup> ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged. All of these effects are associated with marked decreases in GABA-sensitive neuronal calcium conductance (gCa). The net result of barbiturate action is acute potentiation of inhibitory GABAergic tone. Barbiturates also act through potent (if less well characterized) and direct inhibition of excitatory AMPA-type glutamate receptors, resulting in a profound suppression of glutamatergic neurotransmission.

Cellular LocationsMembrane

용도 및 제조

UsesMetharbital is used for the treatment of epilepsy.

관련 반응

0건
반응 기록 만들기
아직 관련 반응이 없습니다

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
굴절률
1.4922 · 1.4922 (estimate)
용해도
DMSO(약간 용해됨), 메탄올(약간 용해됨)
산도 계수 (pKa)
8.45 · 8.45: Fox, Shugar, Bull. Soc. Chim. Belg. 61, 44 (1952)
물리적 상태
고체
색상
흰색에서 황백색까지
수용성
987 mg/L · 987mg/L(상온)
ridadr
3249
포장분류
III
위험 등급
6.1(b)